Advertisement

Topics

Swedish Orphan Biovitrum AB Company Profile

17:53 EST 18th November 2018 | BioPortfolio

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families.

Sobi have a diversified and growth-oriented commercial product portfolio.
Sobi's key therapeutic areas are Inflammation and Genetics & Metabolism.
Sobi's late stage pipeline includes three phase III programs with substantial potential.
Sobi have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners.

Location

Stockholm
Stockholm
Stockholm
Stockholm
SE-112 76
Sweden

Contact

Phone: +46 8 697 20 00


News Articles [545 Associated News Articles listed on BioPortfolio]

Deals this week: Swedish Orphan Biovitrum, Vectura

Swedish Orphan Biovitrum (Sobi) has entered an agreement to purchase the US rights for Synagis from AstraZeneca for $1.5bn. Sobi...Read More... The post Deals this week: Swedish Orphan Biovitrum, Vect...

Swedish Orphan acquires AZ's infectious disease drug

AstraZeneca granted Swedish Orphan Biovitrum marketing rights to infectious disease drug Synagis, or palivizumab.  -More- 

Swedish Orphan Biovitrum Acquires Synagis U.S. Rights

Swedish Orphan Biovitrum AB ADR 2018 Q2 - Results - Earnings Call Slides

Swedish Orphan Biovitrum AB 2018 Q3 - Results - Earnings Call Slides

AstraZeneca Sells Synagis Rights to Sobi

Anglo-Swedish drugmaker AstraZeneca has sold US right for its Synagis infant respiratory drug to Swedish Orphan Biovitrum (Sobi) for an upfront sum of $1.5 billion. The payment consists of $1 billion ...

Swedish Orphan Biovitrum AB's (BIOVF) CEO Guido Oelkers on Merger & Acquisition Conference - Transcript

Swedish Orphan Biovitrum AB (BIOVF) CEO Guido Oelkers on Q3 2018 Results - Earnings Call Transcript

Drugs and Medications [5 Associated Drugs and Medications listed on BioPortfolio]

Nasal decongestant [SUPERVALU INC.]

Equaline 44-112

Kepivance [Swedish Orphan Biovitrum AB (publ)]

These highlights do not include all the information needed to use Kepivance safely and effectively. See full prescribing information for Kepivance.Kepivance® (palifermin) For injection, for intraveno...

Kineret [Swedish Orphan Biovitrum AB (publ)]

These highlights do not include all the information needed to use Kineret safely and effectively. See full prescribing information for Kineret. Kineret® (anakinra) For injection, for subcutaneous use...

Carbaglu [Orphan Europe, SARL]

These highlights do not include all the information needed to use CARBAGLU safely and effectively.  See full prescribing information for CARBAGLU.   CARBAGLU (carglumic acid) TabletsInitial U.S. App...

Carticel [Genzyme Corporation]

These highlights do not include all the information needed to use Carticel safely and effectively. See full prescribing information for Carticel. Carticel® (autologous cultured chondrocytes) For Auto...

PubMed Articles [172 Associated PubMed Articles listed on BioPortfolio]

Orphan drugs: trends and issues in drug development.

Research in rare diseases has contributed substantially toward the current understanding in the pathophysiology of the common diseases. However, medical needs of patients with rare diseases have alway...

An autoregulatory loop controlling orphan nuclear receptor DAX-1 gene expression by orphan nuclear receptor ERRγ.

Dose-Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis.

In the development process for new drugs, dose-finding studies are of major importance. Absence of these studies may lead to failed phase 3 trials and delayed marketing authorization. In our study we ...

Nursing Diagnoses Panorama in a Swedish Forensic Psychiatric Setting Using NANDA-International Taxonomy.

More than 1,000 Swedish hospital beds are occupied by patients in forensic psychiatric settings; their average length of hospitalization is 3-7 years. In this context, nursing diagnoses could be extre...

Development and psychometric evaluation of the Swedish Propensity to Achieve Healthy Lifestyle Scale in patients with hypertension.

To develop and validate a Swedish questionnaire to measure propensity for behaviour change regarding food habits, physical activity and weight reduction in patients with hypertension.

Clinical Trials [165 Associated Clinical Trials listed on BioPortfolio]

Exploring Massage Benefits for Arthritis of the Knee

In 2004, we conducted a pilot randomized, wait list controlled, trial (RCT) of massage therapy for OA of the knee in 68 subjects. That study, supported by CDC grant SIP-14-00, revealed th...

Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease

This is a randomized cross-sectional study of the Swedish population. Blood samples will be collected from a subpopulation in order to estimate the age specific sero-prevalence of the Swed...

The Swedish Two-County Trial of Mammography Screening

Population-based randomized controlled trial carried out in two Swedish counties, Dalarna and Ostergotland to find out the impact of early detection on mortality from breast cancer.

Cohort of Swedish Men

The Cohort of Swedish Men began in 1997, when all men born between 1918 and 1952 and residing in two counties in central Sweden received a questionnaire including about 350 items concernin...

Post Implantation/Post Market Evaluation of the Swedish Adjustable Gastric Band

The purpose of the study is to evaluate the long term safety of the Swedish Adjustable Gastric Band (SAGB) in subjects with an SAGB in place. Specifically it is designed to determine the ...

Companies [203 Associated Companies listed on BioPortfolio]

Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. Sobi have a diversi...

Biovitrum

Biovitrum is one of the largest biopharma companies in Europe. We combine research and development with process development and production of protein-based drugs and marketing of specialist pharmaceut...

Biovitrum AB

Biovitrum is one of the largest biopharma companies in Europe. We combine research and development with process development and production of protein-based drugs and marketing of specialist pharmaceut...

AOP Orphan Pharmaceuticals AG

AOP Orphan is a multinational company with headquarters in Vienna, Austria, focusing on clinical research, development and distribution of medicines for rare and complex diseases....

More Information about "Swedish Orphan Biovitrum AB" on BioPortfolio

We have published hundreds of Swedish Orphan Biovitrum AB news stories on BioPortfolio along with dozens of Swedish Orphan Biovitrum AB Clinical Trials and PubMed Articles about Swedish Orphan Biovitrum AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Swedish Orphan Biovitrum AB Companies in our database. You can also find out about relevant Swedish Orphan Biovitrum AB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record